Table of Contents
| May 2002 (Vol: 2002, Issue: 24) | Next Issue >> |
- Section: Company Profile
-
Kyowa Hakko Kogyo Co., Ltd
- Section: Distribution & Marketing
-
Mayne Pharma to market Virulizin® in Brazil
-
OM Pharma to promote Gynazole-1 treatment in Latin America and Middle East
- Section: General
-
Drug Royalty Companies
-
New Chemical Entities as Potential Opportunities for Drug Delivery Companies
-
Therapy Focus: Anticancer
- Section: Licensing
-
Xenova out-licenses preclinical technology to Genentech
-
Aventis to co-market Genta’s Genasense™
-
King acquires Ortho-Prefest® from J&J
-
Immunex sells cancer drug to Schering AG for US$380 M
- Section: Mergers & Acquisitions
-
IntraBiotics acquires Apothogen
-
Abbott to take full control of Hokuriku Seiyaku
- Section: Research & Development
-
AxCell in collaboration with Mount Sinai School of Medicine
-
Cohesion and Zycos in PEG drug delivery collaboration
-
Neurocrine and Wyeth extend EAAT-3 agreement
RSS